Central Florida Cancer & Blood is categorized under Family Practice Doctors in Ocala, FL and active since 2011.
Central Florida Cancer & Blood was established in 2011, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Ravi K Koti at the company’s single location by writing to 3120 Sw 27th Avenue, Ocala, Florida FL 34471 or by phoning (352) 671-4422. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Central Florida Cancer & Blood |
| Contact Person: | Ravi K Koti |
| Address: | 3120 Sw 27th Avenue, Ocala, Florida 34471 |
| Phone Number: | (352) 671-4422 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Central Florida Cancer & Blood was started in 2011 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Ravi K Koti for inquiries that concern Central Florida Cancer & Blood by calling the company number (352) 671-4422, as your correspondence is most welcome. Additionally, the physical location of the single location of Central Florida Cancer & Blood can be found at the coordinates 29.15638,-82.16899 as well as the street address 3120 Sw 27th Avenue in Ocala, Florida 34471.
For its online presence, you may visit Central Florida Cancer & Blood’s website at and engage with its social media outlets through on Twitter and on Facebook.